CLINICAL_TRIALS
other
· 2025-11-18
Clinical Trial Update: Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.
Summary
Pfizer is providing pre-approval, single-patient expanded access (compassionate use) of etrasimod for ulcerative colitis, enabling treatment ahead of formal reg…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Colitis, Ulcerative | Status: AVAILABLE